Jun 06, 2026
16 MIN READ

How Does the Body Make GLP-1?

Your intestines naturally produce GLP-1 to control hunger and blood sugar. When your body doesn't make enough, semaglutide therapy can restore the signals your metabolism needs to lose weight effectively.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 06, 2026
16 MIN READ

how does the body make glp-1? — PlexusDx GLP-1 education

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Your body manufactures glucagon-like peptide-1 (GLP-1) in specialized intestinal cells called L-cells, which line your small bowel and release this hormone after you eat. The amount your body produces varies based on genetics, diet, and metabolic health—and some people naturally make significantly less than others. Understanding your GLP-1 production capacity is the first step toward choosing the right weight loss strategy.

Where Your Body Produces GLP-1 Naturally

Intestinal L-cells, found primarily in your ileum and colon, manufacture and secrete GLP-1 whenever nutrients enter your digestive system. These cells detect glucose, amino acids, and fatty acids, then release GLP-1 directly into your bloodstream within minutes of eating. The response is automatic—your body has been performing this process since birth, adjusting meal to meal based on what you consume.

L-cells also line your stomach and upper small intestine, creating a distributed network that monitors your entire digestive tract. When food triggers L-cell activation, GLP-1 levels can increase 5- to 10-fold in healthy individuals, though this response weakens in people with obesity or type 2 diabetes. This natural hormone acts as a metabolic messenger, telling your brain you're full and signaling your pancreas to release insulin appropriately.

Why Some People Produce Less GLP-1

Genetic variation significantly influences how much GLP-1 your L-cells produce and how effectively your body responds to it. Research has identified multiple gene variants—including changes in the GLP1R gene—that predict lower natural GLP-1 output and reduced appetite suppression during eating. People carrying these variants may feel hungry sooner, consume larger portions, and experience less metabolic benefit from their own hormone production.

Beyond genetics, obesity itself reduces GLP-1 secretion in a harmful cycle: excess weight dampens L-cell function, lowering hormone production, which allows more overeating, which perpetuates weight gain. Poor diet quality, sedentary behavior, and inflammation also suppress natural GLP-1 responses, making it harder for your body to signal fullness. This is why some individuals struggle with weight loss despite significant effort—their endogenous GLP-1 system is simply underperforming.

The PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R gene and 13 other metabolic pathways, revealing whether your natural GLP-1 production capacity is genetically optimized or compromised. This insight helps confirm whether GLP-1 therapy is strategically appropriate for your biology, rather than guessing based on trial and error.

How GLP-1 Therapy Restores What Your Body Isn't Making

Semaglutide, the active compound in PlexusDx injectable therapy, mimics the GLP-1 your intestines produce naturally but delivers a consistent, therapeutic dose your body cannot generate on its own. Rather than replacing your natural system, semaglutide supplements insufficient endogenous production, essentially providing the appetite control and metabolic signaling your L-cells should be delivering. Starting at $149 per month with no flat per-compound pricing increases, PlexusDx semaglutide injection compensates for genetic or metabolic deficiency in your GLP-1 pathway.

The hormone works through the same receptors your natural GLP-1 targets—slowing gastric emptying so food stays in your stomach longer, increasing satiety signals to your brain, and improving how your body handles blood glucose. Clinical trials show semaglutide users experience sustained weight loss averaging 10-15% of body weight over 68 weeks, with effects persisting as long as therapy continues. Your dose may need to go up to match your individual tolerance and weight loss goals, but your monthly price stays flat—PlexusDx's commitment to transparent, non-punitive dosing.

Unlike fad diets or willpower-dependent strategies, semaglutide therapy addresses the root biological problem: insufficient GLP-1 signaling. By restoring this missing hormonal feedback, you regain normal hunger cues, reduce cravings, and achieve calorie deficit without the constant psychological strain of fighting your own metabolism.

Choosing Between Injectable and Oral GLP-1 Therapy

PlexusDx offers compounded semaglutide in two delivery forms: injectable (starting at $149/month) and oral (starting at $249/month). Injectable semaglutide is absorbed directly into the bloodstream through subcutaneous tissue, providing predictable, high bioavailability and consistent GLP-1 receptor activation. Oral semaglutide must survive stomach acid and intestinal digestion, requiring larger doses and sometimes less reliable absorption—which is why oral pricing begins higher despite comparable clinical outcomes in committed users.

Both forms are manufactured by licensed 503A compounding pharmacies and available nationwide with no insurance requirement or membership fee. Your choice depends on injection comfort, convenience, and cost preference. HSA and FSA accounts cover both options, making PlexusDx therapy accessible whether you have traditional insurance or not. A qualified PlexusDx clinician will help you select the delivery method that aligns with your lifestyle and metabolic goals during your initial consultation.

Genetic Testing and Personalized GLP-1 Selection

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first treatment month) sequences your DNA for variants in the GLP1R gene, GIPR gene, FTO gene, MC4R gene, and 10 additional metabolic pathways affecting 49 distinct peptides. This 150+ insight report reveals whether your body's natural GLP-1 system is genetically compromised, predicting your likelihood of response to semaglutide and whether dual-compound therapy (tirzepatide) might offer superior outcomes. This is not pharmacogenomic testing; it maps your peptide-pathway genetics to optimize compound selection before you invest months in treatment.

Patients with confirmed GLP1R variants often respond exceptionally well to semaglutide because the therapy directly compensates for their genetic deficit. Those with variants affecting additional pathways may benefit from exploring PlexusDx tirzepatide injection (starting at $249/month), which activates both GLP-1 and GIP receptors, engaging broader metabolic circuitry. Genetic insight removes guesswork—you'll know within the first month whether your biology predicts strong semaglutide response or whether alternative PlexusDx compounds warrant exploration.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is GLP-1, and why does my body make it?

GLP-1 is a hormone your intestinal L-cells produce after eating to signal fullness, slow digestion, and regulate blood sugar. Your body manufactures it automatically to prevent overeating and maintain metabolic balance—but some people genetically produce less, contributing to weight gain and hunger dysregulation.

Can I increase my natural GLP-1 production without medication?

Diet changes—especially high-protein, high-fiber meals—can modestly improve L-cell GLP-1 secretion, and weight loss itself restores natural hormone responsiveness. However, if your GLP1R gene carries loss-of-function variants, your maximum natural output may always be insufficient, making semaglutide therapy a more reliable solution.

How much does PlexusDx semaglutide cost, and is it covered by insurance?

PlexusDx compounded semaglutide injection starts at $149 per month with no flat per-compound pricing increases—your dose may go up, but your price won't. The therapy is available nationwide without insurance, and HSA/FSA accounts are eligible for reimbursement.

Is compounded semaglutide as safe and effective as brand-name Ozempic?

PlexusDx semaglutide is manufactured by licensed 503A compounding pharmacies under stringent quality and sterility standards. While not FDA-approved as a finished drug, compounded semaglutide demonstrates equivalent clinical outcomes to brand versions when sourced from credible pharmacies, at significantly lower cost.

Can the Precision Peptide Genetic Test predict how well semaglutide will work for me?

Yes. The test identifies your GLP1R gene variants and 48 other peptide-pathway markers, revealing whether your natural GLP-1 deficit is genetic and predicting your likelihood of strong semaglutide response. Results guide whether semaglutide alone or dual-compound therapy suits your biology best.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves